Advanced company searchLink opens in new window

ASPIRE PHARMA HOLDINGS LIMITED

Company number 09306251

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 May 2024 LIQ03 Liquidators' statement of receipts and payments to 1 March 2024
16 May 2023 LIQ03 Liquidators' statement of receipts and payments to 1 March 2023
06 May 2022 LIQ03 Liquidators' statement of receipts and payments to 1 March 2022
03 Sep 2021 CS01 Confirmation statement made on 28 August 2021 with no updates
25 Aug 2021 AA Total exemption full accounts made up to 31 December 2020
25 Mar 2021 AD01 Registered office address changed from 102 High Street Godalming Surrey GU7 1DS to 6th Floor, 2 London Wall Place London EC2Y 5AU on 25 March 2021
25 Mar 2021 600 Appointment of a voluntary liquidator
25 Mar 2021 LIQ01 Declaration of solvency
25 Mar 2021 RESOLUTIONS Resolutions
  • LRESSP ‐ Special resolution to wind up on 2021-03-02
05 Feb 2021 MR04 Satisfaction of charge 093062510002 in full
02 Sep 2020 AA Group of companies' accounts made up to 31 December 2019
28 Aug 2020 CS01 Confirmation statement made on 28 August 2020 with no updates
23 Jun 2020 AP01 Appointment of Mr Craig Podolsky as a director on 15 June 2020
23 Jun 2020 AP01 Appointment of Mr Jonathan Charles May as a director on 15 June 2020
23 Jun 2020 AP01 Appointment of Mr Gary David Buckley as a director on 15 June 2020
23 Jun 2020 AP03 Appointment of Mr Gary David Buckley as a secretary on 15 June 2020
05 Jun 2020 TM01 Termination of appointment of Debra Joy Roberts as a director on 31 May 2020
05 Jun 2020 TM02 Termination of appointment of Debra Joy Roberts as a secretary on 31 May 2020
14 Feb 2020 CS01 Confirmation statement made on 14 February 2020 with updates
16 Sep 2019 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
04 Sep 2019 PSC02 Notification of Aphl 1 Limited as a person with significant control on 4 September 2019
04 Sep 2019 PSC07 Cessation of Graham Julian Fraser-Pye as a person with significant control on 4 September 2019
04 Sep 2019 PSC07 Cessation of Juno Pharmaceuticals Luxembourg S.A.R.L as a person with significant control on 4 September 2019
04 Sep 2019 MR04 Satisfaction of charge 093062510001 in full
12 Aug 2019 AA Group of companies' accounts made up to 31 December 2018